C4 Therapeutics (CCCC)
Nasdaq • CCCC • US12529R1077
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 43.2% of free float sold short, 16.7 days to cover, cost to borrow 0.56%. Sign up for live short interest data.
Market Cap
395m USD | # 6372 in US
Volume
2.5m shares | 8.49m USD
Shares Outstanding
131.32m
Free Float Shares
78.28% | 102.79m
